BioCentury
ARTICLE | Clinical News

AmpliVue regulatory update

December 24, 2012 8:00 AM UTC

Quidel said FDA granted 510(k) clearance for AmpliVue to detect toxigenic Clostridium difficile bacterial DNA. The product is now available in the U.S. and EU. The hand-held assay which detects C. dif...